LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dermatopathology Specimens Examined by Smartphone-Based Microscopy

By LabMedica International staff writers
Posted on 01 Feb 2016
Image: Phone microscopy slide reading: the technique for reading a slide using the ball-lens phone microscope with a single light-emitting diode (LED) flashlight providing illumination (Photo courtesy of University of Texas Houston Health Science).
Image: Phone microscopy slide reading: the technique for reading a slide using the ball-lens phone microscope with a single light-emitting diode (LED) flashlight providing illumination (Photo courtesy of University of Texas Houston Health Science).
The incorporation of high-resolution cameras into smartphones has allowed for a variety of medical applications including the use of lens attachments that provide telescopic, macroscopic, and dermatoscopic data.

Skin biopsy and the pathologic information that it provides is foundational to the diagnosis and management of dermatologic disease. However, a lack of expertise in dermatopathologic-specimen interpretation in resource-poor areas may impede timely diagnosis and treatment.

Pathologists at the University of Texas Houston Health Science Center (TX, USA) and their collaborators constructed a mobile phone microscope by using a modified method and a 3-mm-diameter sapphire ball lens purchased from Edmund Optics (Barrington, NJ, USA). A total of 1,130 consecutive dermatopathology specimens from mostly community dermatologists were evaluated. The performance characteristics of the smartphone platform were calculated by using conventional light microscopy as the gold standard. The sensitivity and specificity for the diagnosis of melanoma, non-melanoma skin cancers, and other miscellaneous conditions by the phone microscopy platform, as compared with traditional light microscopy, were calculated.

All excisional 101 specimens were excluded because the diagnosis was previously established. Among the 1,021 specimens, 930 (91.1%) were shave biopsies and 91 (8.9%) were punch biopsies from 763 different patients. For 136 basal cell carcinoma cases, the sensitivity and specificity of smartphone microscopy were 95.6% and 98.1%, respectively. The sensitivity and specificity for 94 squamous cell carcinoma cases were 89.4% and 97.3%, respectively. The lowest sensitivity was found in the 15 melanomas at 60%, although the specificity was high at 99.1%. The accuracy of diagnosis of inflammatory conditions and other neoplasms was variable.

The authors concluded that their study demonstrated the potential for a high-performing, low-cost smartphone microscopy system in the diagnosis of cutaneous disease. Studies with larger sample sizes of pigmented lesions, non-melanoma skin cancer (NMSC) subtypes, and dermatologic infections could help improve this modality for point-of-care diagnostics in resource-poor settings. The study was published in the January 2016 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:

University of Texas Houston Health Science 
Edmund Optics


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more